Carter Bankshares (CARE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net income for Q1 2026 was $85.8 million ($3.88 diluted EPS), up from $8.5 million in Q4 2025 and $9.0 million in Q1 2025, driven by a significant one-time transaction gain from the sale of nonperforming loans, which also resulted in substantial credit loss recoveries and improved asset quality.
The sale of nonperforming loans generated $289.5 million in cash, a $65.0 million gain, a $15.0 million net recovery, and released $18.0 million in specific reserves, reducing nonperforming loans from $244.0 million to $24.0 million.
Reinstated quarterly cash dividend and authorized a $10 million share repurchase program, reflecting enhanced capital and liquidity positions, though no shares were repurchased in Q1 2026.
Continued focus on operational efficiency, technology investment, and market expansion in Virginia and North Carolina, with a strategic emphasis on organic growth and prudent expansion.
Announced sale of insurance subsidiary in Q2 2026, expecting a $35.8 million pre-tax gain.
Financial highlights
Net interest income for Q1 2026 was $35.9 million, up 3.8% sequentially and 19.2% year-over-year, with net interest margin rising to 3.08%.
Total noninterest income surged to $71.0 million, mainly due to the $65.0 million transaction gain.
Noninterest expense was $31.0 million, up 10.6% year-over-year, driven by higher salaries, data processing, and professional fees.
Adjusted net income (excluding the transaction) was $8.6 million.
Total assets at $4.8 billion, loans at $3.7 billion, and deposits at $4.2 billion as of March 31, 2026.
Outlook and guidance
Management expects continued loan growth, supported by a healthy pipeline and funding from approximately $450 million in construction commitments over the next 12–18 months.
Strategic focus remains on organic growth, operational efficiency, and market share expansion in target growth markets.
The balance sheet remains slightly liability sensitive, positioning for potential Fed rate cuts to further support margin expansion.
Latest events from Carter Bankshares
- Director elections, executive pay, auditor ratification, and ESG priorities headline the 2026 proxy.CARE
Proxy filing15 Apr 2026 - Votes will be cast on director elections, executive pay, and auditor ratification for 2026.CARE
Proxy filing15 Apr 2026 - Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing2 Dec 2025 - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 202521 Nov 2025 - Earnings rose on higher net interest income and loan growth, with strong capital and liquidity.CARE
Q2 20254 Aug 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Net income fell as a large NPL persisted, but capital and liquidity remain strong.CARE
Q2 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025